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Abstract
Background: The hydrophobic triterpenes, oleanolic and betulinic acid as well as the hydrophilic mistletoe lectins
and viscotoxins possess anticancer properties. They do all occur in combination in European mistletoe (Viscum album L.).
Commercial Viscum album L. extracts are aqueous, excluding the insoluble triterpenes. We have previously shown that
mistletoe lectins and triterpene acids are effective against Ewing sarcoma in vitro, ex vivo and in vivo.
Methods: We recreated a total mistletoe effect (viscumTT) by combining an aqueous extract (viscum) and a triterpene
extract (TT) solubilised with cyclodextrins and analysed the effects of viscumTT and the single extracts on TC-71 Ewing
sarcoma cells in vitro by transcriptomic and proteomic profiling.
Results: Treatment with the extracts strongly impacted Ewing sarcoma cell gene and protein expression. Apoptosis-
associated and stress-activated genes were upregulated, proteasomal protein abundance enhanced and ribosomal and
spliceosomal proteins downregulated. The mechanism of action of viscum, TT and viscumTT in
TC-71 and MHH-ES-1 cells suggests the involvement of the unfolded protein response. While viscum and viscumTT
extract treatment indicate response to oxidative stress and activation of stress-mediated MAPK signalling, TT extract
treatment suggests the involvement of TLR signalling and autophagy.
Conclusions: Since the combinatory extract viscumTT exerts highly effective pro-apoptotic effects on Ewing sarcoma
cells in vitro, this phytopolychemotherapy could be a promising adjuvant therapeutic option for paediatric patients with
Ewing sarcoma.
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Background
Ewing sarcoma is the second most common form of bone
sarcoma in children and adolescents [1], deriving from a
mesenchymal stem cell or neuronal crest cell [2, 3]. Its
pathogenesis results from a balanced translocation of the
EWS gene creating fusion proteins which code for chimeric
transcription factors promoting cell growth [4, 5]. Although
5-year survival in Ewing sarcoma patients is about 70%, the
outcome for patients with metastatic disease or relapse
drops to about 10–20% [1]. Resistance to the cytotoxic
drugs used in conventional chemotherapy often occurs in
persisting, recurrent or relapsed tumours, that may be
avoided by specifically targeting pathogenetic mechanisms
in Ewing sarcoma cells to kill cancer clones before resist-
ance can be developed [6, 7]. Effective agents can also
naturally occur in plant extracts, although their direct
mechanisms of action may not be immediately clear.
The hemiparasite,Viscum album L. (European mistletoe),
contains a large variety of different immunomodulatory
and cytotoxic substances that can be highly effective against
cancer cells. Active agents are primarily viscotoxins and
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mistletoe lectins I-III [8–10], but also include triterpenes
and flavonoids [11–15]. Standardised aqueous mistletoe ex-
tracts are commercially available and popular in comple-
mentary cancer medicine. However, they contain only the
hydrophilic mistletoe lectins and viscotoxins. Mistletoe
lectins and also triterpene acids, such as betulinic acid or
oleanolic acid and its derivatives, have been shown to in-
hibit cell growth and induce apoptosis in melanoma, breast
cancer and leukaemia cells [16–18]. Despite the broad ran-
ging anti-tumour effects of Viscum album L., there is little
known about the signalling pathways affected during
mistletoe-mediated apoptosis. Betulinic acid as well as olea-
nolic acid and its derivatives have been reported to activate
stress-mediated MAPKs in gastric cancer, osteosarcoma,
pancreatic cancer, breast adenocarcinoma, glioma and mel-
anoma cells [19–23]. In leukaemia cells, mistletoe lectins
were shown to activate MAPK8 [16, 24], and Korean
mistletoe lectin was shown to activate TLR4 in dendritic
cells [25]. But also AKT signalling has been implicated dur-
ing mistletoe lectin or oleanolic acid treatment of gastric
cancer, hepatocarcinoma, epidermoid cancer, colon carcin-
oma, ovarian cancer, prostate cancer, osteosarcoma and
trophoblast cells, and oleanolic acid and its derivatives have
been demonstrated to induce MTOR and NFKB1 signalling
in prostate cancer, colon cancer and osteosarcoma cells
[23, 26–34]. We have also previously demonstrated the
therapeutic effect of recombining hydrophilic and hydro-
phobic mistletoe constituents in the viscumTT extract for
Ewing sarcoma (Twardziok et al., 2016, manuscript ac-
cepted 07/2016) and acute leukaemia cells in vitro and in
vivo cancer models [35, 36]. In Ewing sarcoma the mech-
anism leading to apoptosis involves the activation of cas-
pases and the downregulation of the anti-apoptotic MCL1
and the IAP family members BIRC5 and XIAP. The aim
of the present study was to analyse the impact of vis-
cumTT and the single extracts on the transcriptome and
proteome of Ewing sarcoma cells and to further illuminate
the involved signalling pathways.
Methods
Viscum album L. extracts
Viscum and TT extracts were prepared from Viscum
album L. harvested from apple trees (malus) as previously
described [36] by the Birken AG (Niefern-Oeschelbronn,
Germany), who kindly provided the lyophilized viscum and
TT extracts for this study. Intact mistletoe lectin I (ML-I)
was analysed by ELISA in viscum extract [37]. Oleanolic
and betulinic acid were quantified, as a measure of extract
activity, using GC-FID [18]. Lyophilized viscum extract was
reconstituted in PBS (Gibco® Life Technologies, Darmstadt,
Germany) to a final concentration of 2 μg/mL intact ML-I
and <1 μg/mL viscotoxins. Lyophilized TT extract (contain-
ing cyclodextrins) was reconstituted in phosphate-buffered
saline to a final concentration of 4000 μg/mL oleanolic and
350 μg/mL betulinic acid.
Cell culture
Human Ewing sarcoma cell lines were obtained from the
German Collection of Microorganisms and Cell Cultures
(DSMZ, Braunschweig, Germany). The TC-71 and MHH-
ES-1 cell lines were maintained in Iscove’s Modified
Dulbecco’s Medium (Gibco Life Technologies) and RPMI
1640 base medium both supplemented with L-glutamine
(Gibco Life Technologies), respectively. Base media were
supplemented with 10% heat-inactivated FBS (Biochrom,
Berlin, Germany), 100 U/mL penicillin and 100 μg/mL
streptomycin (Biochrom). For assays, TC-71 cells were
seeded into 6-well (2 × 105) or 12-well (1 × 105) microtiter
plates or 25 cm2 (5 × 105) or 75 cm2 (1.5 × 106) cell cul-
ture flasks depending on experimental set-up. MHH-ES-1
cells were seeded into 6-well (4 × 105) or 12-well (2 × 105)
microtiter plates. Cells were cultured 24 h to allow cell
attachment, and treated 24 h with Viscum album L. ex-
tracts added to culture media. Viscum, TT and viscumTT
concentrations were assessed by dose-effect-curves of
apoptosis measurements as previously described [38].
RNA isolation
TC-71 cells were incubated with increasing concentra-
tions of the extracts for 24 h. RNA was isolated using
the NucleoSpin® RNA Kit according to the manufac-
turer’s protocol (Macherey-Nagel, Düren, Germany) in
five independent experiments. Purity and concentration
was determined by OD260/280 on the NanoDrop™ 2000
spectrophotometer (Thermo Scientific, Waltham, MA, USA).
mRNA sequencing and bioinformatics analysis
TC-71 cells were treated once with ~IC50 extract concen-
trations (viscum 2 ng/mL ML-I, TT 50 μg/mL oleanolic
acid, viscumTT 1 ng/mL ML-I + 10 μg/mL oleanolic acid)
for 24 h. After total RNA isolation from treated and
control cells, Illumina TruSeq RNA sample preparation
including a polyA selection step via oligo-dT beads was
used to isolate mRNA and generate cDNA libraries. Sam-
ples were sequenced by paired-end mRNA sequencing on
an Illumina HiSeq 2500 (50 bp reads, n = 1). Reads were
mapped uniquely to human genome hg19 using CLC
genomics software. Normalisation and identification of
differentially expressed genes was performed using DE-
Seq software [39] (Bioconductor open source software) to
calculate fold-change relative to untreated control cells,
false discovery rate (FDR) [40] and p value using the nega-
tive binomial distribution, with p ≤ 0.05 considered as sig-
nificant. The heat map and Venn diagram illustrating
differential gene expression as log2-fold change rela-
tive to untreated control cells was performed by using
the R software package (http://www.r-project.org/). Gene
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enrichment and functional annotation analysis was
performed with the top differentially expressed genes
(p ≤ 0.01) using DAVID Bioinformatics Resources 6.7
NIAID/NIH (http://david.abcc.ncifcrf.gov/).
cDNA synthesis and qPCR validation
Using 2 μg RNA from treated or control TC-71 cells,
cDNA was synthesised using the High Capacity RNA-to-
cDNA Kit according to the manufacturer’s protocol (Ap-
plied Biosystems, Waltham, MA, USA). To confirm
mRNA sequencing results, gene expression was mea-
sured by real-time PCR on the StepOnePlus™ System in
96-well fast plates under standard conditions (10 min,
95 °C; 15 s, 95 °C and 60 s, 60 °C, 40×) using Power SYBR
Green Master Mix including ROX as a passive reference
(Applied Biosystems). The quantitative PCR reactions were
20 μl total volume containing 5 ng cDNA and 500 nM
primers, which were predesigned and purchased from Inte-
grated DNA Technologies (IDT, Leuven, Belgium): DDIT3:
Hs.PT.58.14610020; JUN: Hs.PT.58.25094714.g; MAP2K6:
Hs.PT.58.3312889; GAPDH: Hs.PT.39a.22214836. Primer
efficiency was determined to be 90–100%. Expression
was normalised using GAPDH expression. The rela-
tive expression of genes was calculated by ΔΔCT
method: ΔΔCT = (CT(target,untreated) – CT(ref,un-
treated)) − (CT(target,treated) – CT(ref,treated)); fold-
change =2^(−ΔΔCT) [41].
Proteomic profiling and bioinformatics analysis
TC-71 cells were grown in 25 cm2 cell culture flasks in
triplicate and treated with viscum, TT or viscumTT ex-
tracts at ~ IC50 concentrations (viscum 2 ng/mL ML-I,
TT 50 μg/mL oleanolic acid, viscumTT 1 ng/mL ML-
I + 10 μg/mL oleanolic acid) for 24 h. Cells were har-
vested and lysed under denaturing conditions in a buffer
containing 6 M guanidinium chloride, 10 mM tris(2-car-
boxyethyl)phosphine, 40 mM chloroacetamide and
100 mM Tris pH 8.5. Lysates were sonicated and boiled
at 95 °C for 5 min. Lysates were diluted 1:10 in 10%
acetonitrile in 25 mM Tris, pH 8.5, and 2% of each total
lysate volume was digested with 1 μg trypsin at 37 °C
overnight. Peptides were acidified by adding formic acid
to a final concentration of 1%, desalted using C18 Stage-
Tips (Thermo Scientific, Waltham, MA, USA) and lyo-
philised. Pellets were dissolved in 5% acetonitrile and 2%
formic acid and one quarter of the digest was injected
for nanoflow reverse-phase liquid chromatography (Dio-
nex Ultimate 3000, Thermo Scientific) coupled online to
a Thermo Scientific Q-Exactive Plus Orbitrap mass spec-
trometer (nanoLC-MS/MS). Briefly, the LC separation
was performed using a PicoFrit analytical column
(75 μm ID × 40 cm long, 15 μm Tip ID (New Objectives,
Woburn, MA) packed in-house with 2.1 μm C18 resin
(Reprosil-AQ Pur, Dr. Maisch, Ammerbuch-Entringen,
Germany) under 50 C controlled temperature. Peptides
were eluted using a nonlinear gradient from 2 to 40% solv-
ent B in solvent A over 180 min at 266 nL/min flow rate.
Solvent A was 0.1% formic acid and solvent B was 79.9%
acetonitrile, 20% H2O, 0.1% formic acid). Nanoelectros-
pray was generated by applying 3 kV. A cycle of one full
Fourier transformation scan mass spectrum (300–
1700 m/z, resolution of 35,000 at m/z 200) was followed
by 12 data-dependent MS/MS scans with normalised col-
lision energy of 25 eV. A dynamic exclusion window of
30 s was used to avoid repeated sequencing of the same
peptides. MS data were analysed by MaxQuant (v1.5.0.0)
[42]. The algorithm MaxLFQ [43], which is integrated into
MaxQuant, was used for label free quantification (LFQ).
Peptides were searched against the human proteome Uni-
ProtKB database released in 11/2014 with 88,717 entries,
released in 11/2014, using an FDR of ≤0.01 for proteins
and peptides with a minimum length of seven amino
acids. A maximum of two missed cleavages in the tryptic
digest was allowed. Cysteine carbamidomethylation was
set as a fixed modification, while N-terminal acetylation
and methionine oxidation were set as variable modifica-
tions. Principal component analysis (PCA, Fig. 3b) and a
heat map of the replicates (Fig. 3a) were carried out using
the Perseus software (v1.5.1.6). Gene set enrichment ana-
lysis (GSEA, v2.1.0) [44] was applied to assess a priori de-
fined protein sets with statistically significant expression
differences between treated and control cells. We used
GSEA standard settings, except that minimum size exclu-
sion was set to five and KEGG v2.1.0 as well as reactome
v5.0 was used as the gene set database. The String soft-
ware tool (v10) was used to visualise protein-protein inter-
action networks of proteins up- or downregulated at least
2-fold [45]. Protein nodes that were not integrated into
the protein-protein interaction network were removed.
Western blotting
TC-71 and MHH-ES-1 cells were incubated with vis-
cum, TT or viscumTT in increasing concentrations for
24 h. The cells were washed twice with phosphate-
buffered saline and incubated in Lysis Buffer 17 (R&D
systems, Minneapolis, MN) containing protease inhibi-
tors (complete Protease Inhibitor Cocktail Tablets,
Roche Diagnostics GmbH) to obtain cell lysates. Protein
concentration was determined using Bradford solution
(Bio-Rad, Munich, Germany). TC-71 and MHH-ES-1
cell lysates (30 μg protein/lane) were separated on SDS-
PAGE, transferred to nitrocellulose membranes (Bio-Rad
system) and blocked with 5% non-fat milk in 50 mM
Tris-buffered saline containing 0.05% Tween-20 (TBST)
for 1 h at room temperature. Blots were incubated over-
night at 4 °C in TBST containing 5% BSA and primary
antibody, washed thrice in TBST and incubated 1 h with
HRP-conjugated secondary antibodies (anti-rabbit and
Twardziok et al. BMC Complementary and Alternative Medicine  (2017) 17:237 Page 3 of 14
anti-mouse, Bio-Rad) then visualized by ECL (Thermo
Scientific) on a Molecular Imager ChemiDoc (Bio-Rad).
Primary antibodies were directed against p-MAPK14
(Thr180/Tyr182, #9211 Cell Signaling Technology,
Danvers, MA, USA), LC3B (#2775 Cell Signaling Tech-
nology), EIF2AK3 (#3192, Cell Signaling Technology), p-
MAPK8 (sc-6254, Santa Cruz biotechnology, Dallas, TX,
USA), HSPA5 (#G8918, Sigma-Aldrich) and ß-actin con-
jugated directly to peroxidase (#A3854, Sigma-Aldrich).
Inhibitor treatment and apoptosis measurement
To measure the impact of TLR4 signalling, MAPK14
and MAPK8 activation or oxidative stress on apoptotic
induction, TC-71 cells were pre-incubated with specific
inhibitors for 1 h followed by an incubation with ~ IC50 ex-
tract concentrations for 24 h. Specific inhibitor treatment
included 5–50 μM SB203580 (Cell Signaling Technology),
1 μM – 25 μM SP600125 (Sigma-Aldrich), 1–10 mM N-
acetylcysteine (NAC, Sigma-Aldrich), 0.1–10 μg mL−1
LPS-RS (InvivoGen, San Diego, CA, USA). DMSO (Sigma-
Aldrich) or PBS was added to extracts as solvent control,
depending on the inhibitor diluent. After treatment, cells
were washed twice with PBS, resuspended in 100 μl
binding buffer and stained with APC-conjugated
annexin V (BD Biosciences, Franklin Lakes, NJ, USA),
according to the manufacturer’s protocol, then counter-
stained with 1 μl 1 mg/mL propidium iodide (Sigma
Aldrich). Cells were analysed by flow cytometry (FACSCa-
libur, Becton Dickinson, Heidelberg, Germany), and the
data were evaluated using FlowJo Software (TreeStar,
Ashland, OR, USA).
Statistical analyses
All qPCR experiments were performed in triplicate and
experiments were repeated four times. Results are pre-
sented as mean values ± standard error of the mean
(SEM). Inhibitor treatment and measurement of apoptosis
was repeated thrice independently. The results are also
presented as mean values ± SEM. Western blots were per-
formed in three independent experiments. mRNA sequen-
cing was performed in one experiment, while proteomic
profiling was performed in triplicate. The cut-off for sig-
nificantly deregulated pathways was set to p ≤ 0.01 for
mRNAseq and p ≤ 0.05 and FDR ≤ 0.25 for proteomic pro-
filing. Principal component analysis was performed to
compare differences within the triplicates used for prote-
omic profiling. Protein-protein interaction networks of
proteins up- or downregulated were regarded as significant
by at least 2-fold change with a confidence level of 0.7 [45].
Results
ViscumTT alters the transcriptomic profile
Firstly, to explore global changes asserted by mistletoe
extracts in the Ewing sarcoma cell transcriptome, we
treated TC-71 cells for 24 h with viscum, TT or vis-
cumTT in ~ IC50 concentrations in reference to un-
treated control cells and performed one mRNA
sequencing experiment. mRNA sequencing detected
>62,400 transcripts belonging to >17,300 genes. Treat-
ment with the extracts had a massive impact on the tran-
scriptome of TC-71 cells, as shown in the heat map
(hierarchical clustering) of log2-transformed fold-changes
in gene expression (Fig. 1). Interestingly, treatment with
viscumTT or viscum produced similar transcriptomic pat-
terns of differentially expressed genes and resulted in a
differential expression of >1000 genes, most of which were
upregulated relative to the untreated control cells (Fig. 1).
TT treatment displayed a different transcriptomic pattern
and had a lesser impact on the TC-71 transcriptome, caus-
ing the differential expression of only 249 genes (Fig. 1).
An overview of the differentially expressed genes is also
given in a Venn diagram (Additional file 1: Figure S1).
Several components of immune and cellular stress re-
sponses as well as cell survival and death pathways were
within the genes deregulated by viscumTT, viscum or
TT treatment. The top 40 genes (in terms of p ≤ 0.05)
regulated by viscumTT, viscum or TT treatment of
TC-71 cells are shown in Additional file 2: Tables S1,
Additional file 3: Table S2 and Additional file 4: Table S3,
respectively. For instance, JUN, DDIT3 and CXCL8
(formerly IL8) were upregulated and MAP2K6 was down-
regulated by either viscumTT or viscum treatment within
the top 40 deregulated genes, while KLHDC7B, NUPR1
and CYTH3 (formerly GPR1) were upregulated by TT
treatment. JUN and DDIT3 upregulation and MAP2K6
downregulation were confirmed by qPCR (Fig. 2).
To look more deeply into pathways affected at the tran-
script level by mistletoe extract treatment, we preformed
gene enrichment and functional annotation analysis using
the DAVID bioinformatics tool. Since mRNA-sequencing
experiment was performed only once, we chose a strict
cut-off using exclusively genes with p ≤ 0.01 for differen-
tial expression changes from the control cells. ViscumTT
and viscum treatment impacted functional annotation
clusters for the positive regulation of cell death, response
to reactive oxygen species/oxidative stress and MAPK sig-
nalling, while TT affected clusters for Toll-like receptor
signalling, positive regulation of cell death and inflamma-
tory response (Table 1). Taken together, the combined vis-
cumTT extract as well as both single extracts altered
expression of many genes, mostly upregulating them, in
the TC-71 Ewing sarcoma cell line. ViscumTT or viscum
treatment of TC-71 cells indicates a transcriptomic
upregulation of cell stress and MAPK signalling genes,
while TT appears to involve inflammatory response/TLR
signalling, with both extract components transcrip-
tionally exerting a pro-apoptotic effect on TC-71
Ewing sarcoma cells.
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ViscumTT alters the proteomic profile
We next extended our investigations of mistletoe extract
component effects to changes exerted on the TC-71
Ewing sarcoma cell proteome using LC − MS/MS tech-
nology. We examined the same temporal and dose re-
sponse window (24 h and ~ IC50 concentrations) as for
transcriptomic changes. To get more reliable results,
TC-71 cells were treated in three independent experi-
ments with viscumTT, viscum or TT in reference to un-
treated control cells followed by subsequent analysis by
LC − MS/MS. More than 3 × 104 MS spectra were identi-
fied in each sample, which could be mapped to 3554
proteins in total. The ion intensities were log2-trans-
formed and normalised using the z-score by Perseus soft-
ware and then plotted as a heat map (hierarchical
clustering) to display the relative protein expression levels
in the different TC-71 cell treatments and untreated con-
trol cells. Similar to the transcriptomic results, the heat
map displayed an impressive alteration of the proteome
after treatment with viscumTT or viscum compared to
control cells, whereas TT treatment showed fewer
changes (Fig. 3a). Principal component analysis verified
good compliance between the experimental replicates
(Fig. 3b). Therefore, LFQ ion intensities from the experi-
mental replicates were averaged for pathway analyses, only
valid values were used. The top 40 differentially expressed
proteins (in terms of p ≤ 0.05) are presented in Additional
file 5: Tables S4, Additional file 6: Table S5 and Additional
file 7: Table S6. To look more deeply into pathways af-
fected at the protein level by mistletoe extract treatment,
we preformed gene set enrichment analysis using the
GSEA bioinformatics tool. Downregulated proteins after
treatment with viscumTT, viscum or TT related to
ribosome/translation and transcription (Table 2). Protein-
protein interaction network analyses of proteins downreg-
ulated by at least 2-fold revealed for viscumTT or viscum
Fig. 1 ViscumTT alters the transcriptomic profile. TC-71 cells were incubated for 24 h with viscumTT, viscum or TT in ~ IC50 concentrations
followed by mRNA sequencing. Gene expression was calculated as the relative log2-fold change of untreated control cells in one experiment
(p ≤ 0.05). Heat map displays genes upregulated relative to untreated control cells in red and downregulated genes in green
Fig. 2 ViscumTT alters the expression of genes involved in MAPK signalling. TC-71 cells were incubated for 24 h with viscumTT, viscum or TT in ~ IC50
concentrations. The changes in JUN, DDIT3 and MAP2K6 expression detected using mRNA sequencing were validated using qPCR. Gene expression
relative to untreated control cells was calculated from qPCR data using the ΔΔCT method. Bars represent the mean fold-change (log10 ± SEM, error bars)
in gene expression in treatment groups from four independent qPCR experiments and one mRNA sequencing experiment
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treatment proteins involved in the ribosome and spliceo-
some, whereas TT treatment was not linked with any
functional protein networks (Fig. 3c). Gene set enrichment
analysis also revealed that viscumTT, viscum or TT treat-
ment upregulated proteins linked with aminoacyl-tRNA
biosynthesis and the proteasome. Additionally, treatment
with viscumTT or viscum also upregulated proteins asso-
ciated with the regulation of apoptosis, protein folding,
PERK-regulated gene expression, MAP kinase activation
downstream of the toll-like receptor and the immune sys-
tem (Table 3). Protein-protein interaction network ana-
lyses of proteins upregulated at least 2-fold by viscumTT
treatment implicated both the protein processing network
in the endoplasmic reticulum (ER) and the proteasome,
while viscum treatment implicated aminoacyl-tRNA syn-
thesis and the proteasome (Fig. 3c). Our data indicate that
treatment with viscum, TT or the combined viscumTT ex-
tracts results in a reduction of proteins related to the ribo-
some and spliceosome, while increasing proteins associated
with the proteasome. Treatment with either viscumTT or
viscum also triggers protein upregulation associated with
apoptosis, protein folding and MAPK signalling.
ViscumTT induces cellular stress responses
We next aimed to analyse the activation of cellular stress
responses upon mistletoe extract treatment using western
blotting to validate corresponding hints from transcrip-
tomic and proteomic results. Activation of stress-mediated
MAPK signalling by viscumTT and viscum was confirmed
by increased phosphorylation of MAPK8 (formerly JNK)
and MAPK14 (formerly p38/MAPK) in TC-71 and MHH-
ES-1 cells 24 h after treatment with the extracts (Fig. 4a).
All mistletoe extracts upregulated expression of the HSPA5
ER-chaperone protein, indicating response to cellular stress
(e.g. oxidative stress or ER stress) by activation of the un-
folded protein response (Fig. 4a). ViscumTT and viscum
also reduced levels of the EIF2AK3 ER-stress sensor
protein, whereas TT slightly increased EIF2AK3 levels
(Fig. 4a). Since ER stress is linked to autophagy [46, 47], we
next checked LC3B expression, whose conversion from
LC3B-I to LC3B-II is a marker for autophagy. Vis-
cumTT and TT increased LC3B-II levels in TC-71
cells, whereas only TT increased LC3B-II levels in
MHH-ES-1 cells (Fig. 4a).
In order to further analyse the role of stress-mediated
MAPK or TLR signalling and oxidative stress in mistletoe-
mediated apoptosis of Ewing sarcoma cells, TC-71 cells
were treated with viscumTT, viscum or TT for 24 h in the
absence or presence of the SB203580 MAPK14 inhibitor,
the SP600125 MAPK8 inhibitor, the LPS-RS TLR4 inhibi-
tor or the antioxidant NAC. 5 μM MAPK8 and 10 μM
MAPK14 inhibitor treatment was not able to prevent
apoptotic induction by mistletoe extracts. Western blot
analyses of TC-71 cell lysates after inhibitor treatment re-
vealed no reduction in MAPK8 phosphorylation and, un-
expectedly, enhanced MAPK14 phosphorylation (Fig. 4b).
Higher MAPK8 and MAPK14 inhibitor concentrations (up
to 50 μM SB203580 and 25 μM SP600125), as well as
higher concentrations of the other used inhibitors (Table
3), all increased apoptosis in TC-71 cells. Pre-treatment
with the antioxidant NAC (5 mM), however, reduced
apoptosis by 21% after viscum treatment and ~13% after
viscumTT treatment (Fig. 4c). LPS-RS (0.1 μg/mL), which
binds TLR4 but prevents receptor activation, reduced TT-
mediated apoptosis by ~20% (Fig. 4c). Taken together,
these data indicate that viscumTT, viscum and TT activate
the unfolded protein response. TT extract treatment sug-
gests the activation of TLR4 signalling and autophagy,
while viscumTT and viscum indicate the induction of oxi-
dative stress and stress-mediated MAPK signalling. Since
mistletoe extracts appear to trigger multiple pathways sen-
sitizing Ewing cells to apoptosis, inhibiting single pathways
Table 1 Significantly regulated KEGG pathways in TC-71 cells treated 24 h with viscumTT, viscum or TT versus untreated control cells
Extract Functional annotation # Genes p-Value FDR
ViscumTT MAPK signalling pathway 15 6.84 × 10^-6 6.70 × 10^-4
Positive regulation of cell death 15 1.54 × 10^-4 1.54 × 10^-2
Toll-like receptor signalling pathway 8 3.24 × 10^-4 1.58 × 10^-2
Oxidative stress response 6 1.06 × 10^-3 1.95 × 10^-2
Apoptosis 19 4.41 × 10^-5 2.84 × 10^-2
Viscum Response to reactive oxygen species 8 2.59 × 10^-6 1.35 × 10^-3
Response to organic substance 19 2.17 × 10^-5 7.49 × 10^-3
Positive regulation of cell death 12 8.81 × 10^-4 7.34 × 10^-2
MAPK signalling pathway 10 1.75 × 10^-3 1.43 × 10^-1
TT Toll-like receptor signalling pathway 3 4.86 × 10^-2 7.64 × 10^-1
Positive regulation of cell death 5 4.52 × 10^-2 9.95 × 10^-1
Inflammatory response 5 1.79 × 10^-2 1.00 × 10^+0
*p ≤ 0.05 and FDR ≤ 0.1 regarded as significant
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Fig. 3 (See legend on next page.)
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remained insufficient to prevent apoptosis in combination
with extract treatment.
Discussion & conclusions
ViscumTT reconstitutes the aqueous lectins and viscotox-
ins as well as the hydrophobic (with cyclodextrins solubi-
lised) triterpene acids of mistletoe into a defined total
extract, combining all components predicted to have cyto-
toxic properties. ViscumTT extract treatment significantly
altered both the transcriptome and proteome of TC-71
cells affecting cellular stress response pathways related to
cell death. Upregulation of cellular stress associated pro-
teins was also confirmed in MHH-ES-1 cells. While vis-
cum treatment alone displayed similar effects on the
transcriptome and proteome of TC-71 cells, the TT extract
alone showed different and less alterations. On the one
hand, it is possible that viscumTT and TT treatment
displayed different significantly deregulated genes and
(See figure on previous page.)
Fig. 3 ViscumTT alters the proteomic profile. TC-71 cells were treated as biological triplicates with viscumTT or each single extract (~ IC50) for
24 h and analysed by LC − MS/MS. a To display differential protein expression in sample cohorts, a heat map was created by Perseus software
using the z-score (standard score) of log2-transformed ion intensities. b Principal component analysis of the replicates was performed to compare
the effects of Viscum album L. extract treatment. c String network analysis of the averaged replicates was performed to detect protein-protein
interaction networks. Proteins indicated in red belong to the specified KEGG pathway
Table 2 Significantly regulated KEGG and Reactome pathways in TC-71 cells treated 24 h with viscumTT, viscum or TT versus untreated
control cells
Extract Pathway # Proteins p-Value q-Value
>Downregulated
Viscum Ribosome 75 0.00 0.00
Transcription 57 0.00 9.64 × 10^+3
Translation 122 7.95 × 10^-3 1.80 × 10^-1
TT Ribosome 76 0.00 8.58 × 10^-3
Transcription 59 0.00 3.18 × 10^-2
Translation 123 7.11 × 10^-3 2.10 × 10^-1
ViscumTT Ribosome 76 0.00 0.00
Transcription 59 0.00 0.00
Translation 124 5.95 × 10^-3 1.20 × 10^-1
>Upregulated
Viscum Aminoacyl-tRNA biosynthesis 22 0.00 0.00
Proteasome 35 2.96 × 10^-3 9.81 × 10^-2
Protein folding 28 2.98 × 10^-3 3.89 × 10^-2
PERK regulated gene expression 10 1.27 × 10^-2 6.36 × 10^-2
MAP kinase activation in TLR cascade 8 5.64 × 10^-2 1.15 × 10^-1
Immune system 175 0.00 1.51 × 10^-1
TT Aminoacyl-tRNA biosynthesis 22 0.00 0.00
Proteasome 35 1.08 × 10^-2 3.48 × 10^-2
ViscumTT Aminoacyl-tRNA biosynthesis 22 0.00 0.00
Proteasome 35 0.00 5.72 × 10^-2
Regulation of apoptosis 38 0.00 3.10 × 10^-2
PERK regulated gene expression 10 1.80 × 10^-2 6.42 × 10^-2
Immune system 175 3.00 × 10^-3 7.35 × 10^-2
Protein folding 28 1.42 × 10^-2 7.91 × 10^-2
MAP kinase activation in TLR cascade 8 3.90 × 10^-2 7.95 × 10^-2
Apoptosis 69 2.85 × 10^-2 1.59 × 10^-1
*p ≤ 0.05 and q ≤ 0.25
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proteins due to the very different olanolic acid concentra-
tions used in TT and the synergistically apoptosis-inducing
viscumTT extract to reach IC50 (TT 50 μg/mL oleanolic
acid, viscumTT 10 μg/mL oleanolic acid), while the differ-
ence between ML-1 concentration in viscum (2 ng/mL
ML-1) and viscumTT (1 ng/mL ML-1) extract treatment
were more alike. On the other hand, it is conceivable that
TT-activated pathways are different from those activated
by viscum or viscumTT. We have previously demonstrated
that viscum and even more, viscumTT effectively induced
apoptosis in Ewing sarcoma cells in vitro and ex vivo
Table 3 Tested inhibitors
Inhibitor Concentration Tolerance
SB203580 5–50 μM 10 μM
SP600125 10 nM - 25 μM 5 μM
LPS-RS 0.1–10 μg/mL 0.1 μg/mL
NAC 1–10 mM 10 mM
Fig. 4 ViscumTT induces cellular stress responses. a TC-71 and MHH-ES-1 cells were treated with increasing concentrations of viscumTT (ML-I 1–
40 ng/mL + OA 10–60 μg/mL), viscum (ML-I 1–40 ng/mL) or TT (10–60 μg/mL) for 24 h. Activation of stress-mediated MAPK signalling (p-MAPK8,
p-MAPK14), cellular stress/unfolded protein response (EIF2AK3, HSPA5) and autophagy (LC3BI/II) were assessed using western blotting. β-actin was
used as loading control, and images shown are representative for three independent experiments. Mistletoe lectin (ML) and oleanolic acid (OA)
concentrations were used as a measure of viscum and TT active agent extract concentration, respectively. b TC-71 cells were treated with viscumTT,
viscum or TT (~ IC50 concentration) for 24 h in the presence of DMSO (inhibitor solvent control), 10 μM SB203580 or 5 μM SP600125 to inhibit MAPK14
or MAPK8 activation, respectively. Inhibition of MAPK activation was not detected within the used inhibitor concentrations in whole-cell extracts using
western blotting. β-actin was used as loading control, and images are representative for results from three independent experiments. c TC-71 cells
were treated with viscumTT, viscum or TT (~ IC50 concentration) for 24 h in the absence or presence of the TLR4 inhibitor, LPS-RS (0.1 μg/mL), or the
antioxidant, N-acetylcysteine (NAC, 5 mM). Apoptosis was flow cytometrically assessed following annexin V/propidium iodide staining. Bars show the
percentage of apoptosis inhibition is shown in bars (±SEM) from three independent experiments
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accompanied by a loss of mitochondria membrane poten-
tial and activation of CASP-8, −9 and −3, while TT alone
showed only moderate apoptosis induction without a
significant loss of mitochondria membrane potential and
activation of CASP-8, −9 and −3. However, TT potentiates
the effect of viscum resulting in a synergistic apoptosis-
induction by viscumTT (Twardziok et al. 2016, manu-
script accepted).
We show here that viscum, TT and total mistletoe vis-
cumTT extract affect different transcriptomic changes in
Ewing sarcoma TC-71 cells. Both, viscumTT and viscum,
upregulated JUN and other genes involved in cell death,
MAPK signalling and oxidative stress. TT upregulated
genes involved in TLR signalling and cell death as well
as genes involved in inflammatory response. Although
our results are preliminary due to a limited validity of
one single mRNA-sequencing experiment for each ex-
tract treatment, others reported similar findings after
mistletoe extract treatment. For instance, Yang et al. re-
ported that recombinant mistletoe lectin differentially
regulated several genes in the MAPK signalling cascade
in hepatocellular carcinoma cells [26]. Furthermore, a
similar transcriptomic profile involving apoptosis and
MAPK signalling pathway was shown in breast cancer
cells using DNA microarray chips after treatment with
an commercial aqueous mistletoe extract [48]. Interest-
ingly, they showed that aqueous mistletoe extracts from
oak and apple tree hosts more strongly upregulate im-
mune defence and stress response in breast cancer cells,
whereas aqueous extracts from the host tree white fir
affect cell-cell adhesion and cytoskeleton pathways. In
line with this, our extracts from the apple tree as host
evoked cellular stress and immune defence responses.
We further show that viscumTT, viscum and TT affect
different proteomic changes in TC-71 cells. Treatment
with the extracts resulted in the downregulation of pro-
teins involved in translation and transcription/spliceosome
and an upregulation of proteins involved in aminoacyl-
tRNA biosynthesis and the proteasome. ViscumTT and
viscum contain mistletoe lectins, which are classified as
ribosome-inactivating proteins type-II provoking a
breakdown of translation [49–51] leading to proteasomal
degradation. Ribosome-inactivating proteins type-II have
n-glycosidase activity removing single adenines from
rRNA and they were originally thought to act exclusively
on ribosomes, but there is evidence growing that they are
also able to inactivate non-ribosomal nucleic acid substrates
[52, 53]. Therefore, it is conceivable that they also affect the
spliceosome, which consists of snRNAs and protein com-
plexes. ViscumTT and viscum treated TC-71 cells also dis-
played an upregulation of proteins involved in protein
folding, regulation of apoptosis, immune system and
MAPK activation correlating with the transcriptomic re-
sults and suggesting that viscumTT and viscum have an
impact on MAPK signalling and protein folding. Taken to-
gether, our transcriptomic and proteomic data showed that
the triterpene extract TT had a lower influence on the
transcriptome and proteome of TC-71 cells than vis-
cum and viscumTT, which displayed similar profiles.
The mistletoe extracts affect transcription, translation
and the proteasome and they affect cellular stress and
inflammatory responses. However, the similar proteomic
and transcriptomic profiles of viscumTT and viscum
treated TC-71 cells suggest that the synergistic effect of
viscumTT is not created on transcriptional or transla-
tional level.
Our deeper assessment of the affected signalling path-
ways upon mistletoe treatment revealed the activation
(phosphorylation) of stress-mediated MAP kinases
MAPK8 and MAPK14 by viscumTT and viscum in TC-
71 and MHH-ES-1 cells. In agreement with our results,
others have shown the activation of MAPK8 signalling
by an aqueous European and Korean mistletoe extract in
leukaemia and hepatocarcinoma cells [16, 54, 55]. Other
ribosome-inactivating proteins as Ricin or Shiga toxins
also activate MAPK8 and MAPK14 in human monocytes
and macrophages [56–58]. Contrary to our results, the
triterpenes oleanolic and betulinic acid were also shown
to activate MAPK8 and MAPK14 in melanoma, pancre-
atic cancer and osteosarcoma cells and hypertrophic scar
fibroblasts [19, 21, 59]. Since the activation of MAPK8
and MAPK14 is stress-mediated resulting in apoptosis
and because our pathway analyses displayed response to
oxidative stress and TLR signalling, we next investigated
the impact of MAPK8, MAPK14 and TLR4 inhibitors and
the anti-oxidant NAC on apoptosis induction in TC-71
cells upon treatment with the extracts. TT-mediated
apoptosis was reduced when cells were pre-treated with
the TLR4 antagonist LPS-RS suggesting the involvement
of TLR4 signalling by TT treatment. TLR4 signalling has
been described in mouse splenocytes after treatment with
an oleanolic acid derivative [60]. With regard to oxidative
stress, NAC pre-treatment slightly reduced apoptosis by
viscumTT and viscum indicating that oxidative stress is
involved in viscumTT- and viscum-mediated apoptosis. In
line with our results, the induction of oxidative stress by
aqueous mistletoe extracts was shown in leukaemia and
hepatocarcinoma cells [16, 55]. However, an oleanolic acid
derivative was also reported to induce oxidative stress in
ovarian cancer cells [61]. Notably, the applied MAPK14
and MAPK8 inhibitors (up to 10 μM SB203580, 5 μM
SP600125) were not able to inhibit the activation of the
kinases and to prevent the induction of apoptosis by vis-
cumTT or viscum. Higher concentrations of the inhibitors
resulted in a significant loss of cell viability demonstrating
the cytotoxic potential of the inhibitors in TC-71 cells
(data not shown). Others have used superior concentra-
tions (up to 30 μM SB203580 or SP600125) to achieve a
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block in mistletoe mediated apoptosis induction without a
loss of cell viability in leukaemia and hepatocarcinoma
cells suggesting that higher concentrations might be ne-
cessary to effectively block apoptosis [16, 55, 62]. How-
ever, it is likely that the MAPK pathway is not the major
pathway engaged by the extracts since viscumTT and vis-
cum displayed an impressive impact on the transcriptome
and proteome of TC-71 cells suggesting that the reasons
for the apoptosis induction by the extracts are manifold.
In summary, our deeper assessment of the activated
signalling pathways indicates the involvement of TLR4
signalling for the TT extract and the activation of the
stress-mediated MAPK signalling and oxidative stress for
viscum and viscumTT. However, a deeper investigation of
the activated pathways is needed.
Since there is a crosstalk between oxidative stress and
the unfolded protein response and ER stress is also linked
to MAPK8 activation [63–66], we analysed the protein ex-
pression of the ER chaperone protein HSPA5 [67] and the
ER stress sensor protein EIF2AK3 [68, 69] in TC-71 and
MHH-ES-1 Ewing sarcoma cells. We detected an upregu-
lation of HSPA5 by viscumTT and both single extracts in
both cell lines suggesting response to oxidative or ER
stress by activation of the unfolded protein response.
However, our results are preliminary and need further
specific analyses for validation. Interestingly, the induction
of HSPA5 and DDIT3 (formerly CHOP) leading to ER
stress was already reported for a commercial aqueous ex-
tract in leukaemia cells [16]. We also detected a transcrip-
tional an upregulation of DDIT3 after treatment with
viscumTT or both single extracts. Other ribosome-
inactivating proteins like Ricin and Shiga toxins were also
shown to activate the unfolded protein response in human
breast and colon cancer cell lines [70] and a rat renal
tubular epithelial cell line [71]. Furthermore, the naturally
occurring triterpenoid celastrol induced the unfolded pro-
tein response in head and neck cancer cell lines [72]. Not-
ably, viscumTT and viscum treatment concurrently
displayed a decrease of EIF2AK3, whereas TT treatment
showed a slight upregulation matching ER stress. Others
demonstrated the induction of apoptosis by ER stress in
HeLa cells after treatment with an oleanolic acid deriva-
tive [73]. Proteomic investigation of betulinic acid-
induced apoptosis in HeLa cells also displayed the induc-
tion of ER stress [74]. Furthermore, an oleanolic acid
derivative was shown to trigger ER stress leading to
MAPK8-dependent apoptosis [75]. Because ER stress
is connected to autophagy [46, 47, 76, 77], we also
analysed the expression of the autophagy marker LC3B.
The triterpene extract TT increased LC3B-II expression
in both cell lines indicating enhanced autophagic activity.
Consistent with our results, the triterpenes ursolic, betuli-
nic or oleanolic acid and its derivatives were reported to
induce autophagy in glioblastoma, breast cancer, prostate
cancer, myeloma, KRAS transfected MCF10A breast
epithelial cells as well as in Human Embryonic Kid-
ney 293 cells, human hepatic cells, immortalized
breast epithelial, gastric mucosal and primary bladder
epithelial cells [78–84]. Others, by contrast, reported
autophagy induction by Korean mistletoe lectin in
placenta-derived mesenchymal stem cells [85]. In
summary, viscumTT and the single extracts viscum
and TT influence protein folding and indicate the in-
volvement of the unfolded protein response and au-
tophagy (TT).
In conclusion, we provide a first deep insight into
the effects of single and combined mistletoe extracts
in Ewing sarcoma cells in vitro. ViscumTT and both
single extracts induce diverse cellular stress responses
and influence protein folding. While viscumTT and
viscum suggest the activation of the stress-mediated
MAPK signalling and induction of oxidative stress,
the TT extract indicates the induction of autophagy
and TLR4 signalling. As viscumTT and viscum appear
to activate the same signalling pathways differing
from TT-activated pathways, the synergistic effect of
viscumTT demonstrated in our previous work cannot
be explained so far. However, the results suggest that
the synergistic effect of viscumTT is created by other
mechanisms. Nevertheless, viscumTT, which combines
the anticancer effects of hydrophilic and hydrophobic
mistletoe compounds, may represent a promising ad-
juvant phytopolychemotherapeutic therapy option for
Ewing sarcoma patients.
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